| |
| Issue |
Title |
| |
| Vol 16, No 4 (2024) |
Cost-effectiveness of vaccination against HPV of adolescent girls in the regions of Russian Federation |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, S. M. Kharit, Yu. V. Lobzin |
| |
| Vol 15, No 4 (2023) |
Cost-effectiveness of gender neutral vaccination of adolescents against human papillomavirus infection in the Russian Federation |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, S. M. Kharit, K. K. Tikhomirova, Yu. V. Lobzin |
| |
| Vol 14, No 5 (2022) |
Сost-effectiveness of pentavalent rotavirus vaccination in the Russian Federation |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, S. M. Kharit, S. V. Rychkova, Yu. V. Lobzin |
| |
| Vol 13, No 4 (2021) |
Cost-effectiveness of meningococcal vaccination of infants in the Russian Federation |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, A. A. Vilnits, S. M. Kharit, Yu. V. Lobzin |
| |
| Vol 13, No 3 (2021) |
Cost effectiveness analysis of universal varicella vaccination in the Russian Federation |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, S. M. Kharit, I. V. Babachenko, L. N. Konovalova, S. V. Rychkova, A. N. Uskov, Yu. V. Lobzin |
| |
| Vol 11, No 1 (2019) |
INFLUENZA VACCINATION OF CHILDREN OF PRESCHOOL AGE IN THE RUSSIAN FEDERATION: COST-EFFECTIVENESS OF QUADRIVALENT VACCINE |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, D. M. Danilenko, D. A. Lioznov, L. S. Karpova, S. M. Kharit, E. V. Mikitenko, A. N. Uskov, A. S. Kolbin, L. N. Konovalova, Yu. V. Lobzin |
| |
| Vol 10, No 2 (2018) |
Comparative clinical and economic evaluation of two alternative antiviral therapy regimens for influenza patients |
Abstract
PDF (Rus)
|
|
I. I. Tokin, V. V. Tsvetkov, G. S. Golobokov |
| |
| Vol 9, No 4 (2017) |
COST-EFFECTIVENESS OF ANTIVIRAL THERAPY IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C (GENOTYPE 1) WITH VARIOUS SEVERITY OF FIBROSIS STAGE |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, D. A. Gusev, A. N. Uskov, I. V. Shestakova, Yu. V. Lobzin |
| |
| Vol 9, No 3 (2017) |
THE MAIN DIRECTIONS OF ART IN HIV-INFECTED CITIZENS OF THE LEBANESE REPUBLIC |
Abstract
PDF (Rus)
|
|
Zh. V. Mironenkova, M. A. Moussawi, A. F. Davletianova |
| |
| Vol 9, No 2 (2017) |
Cost-effectiveness of antiviral therapy in treatment-naive patients with chronic hepatitis C (genotype 1) |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, D. A. Gusev, A. N. Uskov, L. N. Konovalova, Yu. V. Lobzin |
| |
| Vol 9, No 1 (2017) |
PROTEASE INHIBITOR NARLAPREVIR IN THERAPY OF HEPATITIS C VIRUS GENOTYPE 1 INFECTION IN TREATMENT-NAÏVE PATIENTS WITHOUT CIRRHOSIS: PHARMACOECONOMIC EVALUATION |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, D. A. Gusev, A. N. Uskov, L. N. Konovalova, Yu. V. Lobzin |
| |
| Vol 8, No 3 (2016) |
Cost-effectiveness of quadrivalent human papillomavirus vaccination in adolescent girls |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, S. M. Kharit, A. S. Lisianskaya, A. N. Uskov, Yu. V. Lobzin |
| |
| Vol 8, No 3 (2016) |
Cost-effectiveness of narlaprevir in the chronic hepatitis C (genotype 1) therapy in treatment-naïve patients and relapsers |
Abstract
PDF (Rus)
|
|
D. A. Gusev, A. V. Rudakova, A. N. Uskov, L. N. Konovalova, Yu. V. Lobzin |
| |
| Vol 8, No 1 (2016) |
Сost-effectiveness of the second wave of protease inhibitors in the treatment of chronic hepatitis C (genotype 1) in patients not previously treated with antiviral drugs, and for relapsed disease |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, D. A. Gusev, A. N. Uskov, L. N. Konovalova, Yu. V. Lobzin |
| |
| Vol 7, No 4 (2015) |
Cost-effectiveness of antiviral therapy in chronic hepatitis C (G1) |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, D. A. Gusev, A. N. Uskov, Yu. V. Lobzin |
| |
| Vol 7, No 1 (2015) |
Antiviral therapy in chronic hepatitis C (G1) in Russia: cost and effectiveness |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, D. A. Gusev, A. N. Uskov, Yu. V. Lobzin |
| |
| Vol 6, No 4 (2014) |
The cost-effectiveness of different diagnostic options of TB among HIV-infected patients |
Abstract
PDF (Rus)
|
|
V. E. Shumlyanskaya, A. V. Rudakova |
| |
| Vol 6, No 3 (2014) |
The usage of systemic enzyme therapy in combination treatment of erysipelas: the assessment by the pharmacoeconomic positions |
Abstract
PDF (Rus)
|
|
N. Yu. Pshenichnaya, T. V. Moskovaya, A. V. Chistyakov, A. V. Usatkin |
| |
| Vol 6, No 1 (2014) |
Cost analysis of the first line antiretroviral therapy in Russian Federation |
Abstract
PDF (Rus)
|
|
A. V. Rudakova |
| |
| Vol 6, No 1 (2014) |
Сost assessment of HIV prophylaxis of mother to child transmission and family planning program among HIV infected women |
Abstract
PDF (Rus)
|
|
A. V. Samarina |
| |
| Vol 6, No 2 (2014) |
Assessment of reduction of rotavirus infection burden in case of vaccination with a pentavalent vaccine in Russian Federation |
Abstract
PDF (Rus)
|
|
A. V. Rudakova, S. M. Kharit, A. N. Uskov, Yu. V. Lobzin |
| |
| 1 - 21 of 21 Items |
|
.png)
.png)
